Clinical Trial Update: Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Haporine-S for moderate to severe dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Haporine-S

Snippet

Sponsor: DH Bio Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED